Igene Biotechnology, Inc.
IGNE
$0.00
$0.000.00%
OTC PK
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | 09/30/2009 | |
|---|---|---|---|---|---|
| Net Income | -646.34% | -43.32% | -178.79% | 71.73% | 114.38% |
| Total Depreciation and Amortization | -6.97% | -7.91% | -8.65% | -79.08% | -31.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -95.70% | -- |
| Total Other Non-Cash Items | -114.54% | 197.40% | 142.80% | -105,544.44% | 67,322.22% |
| Change in Net Operating Assets | 104.90% | -95.60% | -82.53% | 18.64% | -410.26% |
| Cash from Operations | -275.93% | -154.94% | 96.47% | -285.83% | 773.17% |
| Capital Expenditure | -- | -205.63% | -- | -2.82% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -200.00% | -- | -2.82% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 128.74% | -103.51% | -153.33% | 139.04% | 51.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -279.18% | -150.76% | 96.55% | -285.87% | 460.58% |